Company Filing History:
Years Active: 2017-2019
Title: Joseph Lustgarten: Innovator in Cancer Treatment
Introduction
Joseph Lustgarten is a notable inventor based in Scottsdale, AZ (US). He has made significant contributions to the field of cancer treatment through his innovative research and patents. With a total of 2 patents, Lustgarten is dedicated to advancing medical science and improving patient outcomes.
Latest Patents
Lustgarten's latest patents focus on blocking IL-9 signaling in conjunction with chemotherapy to treat cancer. This document outlines methods and materials related to using inhibitors of IL-9 signaling alongside chemotherapy for treating solid tumors. Specifically, it provides insights into using anti-IL9 antibody preparations to enhance the effectiveness of chemotherapy in treating cancers such as breast and colon tumors. The methods aim to reduce the growth rate of these solid tumors within mammals, showcasing Lustgarten's commitment to innovative cancer therapies.
Career Highlights
Joseph Lustgarten is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to contribute to groundbreaking research in oncology. His work is characterized by a focus on developing novel therapeutic strategies that can significantly impact cancer treatment.
Collaborations
Lustgarten collaborates with esteemed colleagues, including Dominique B Hoelzinger and Sandra J Gendler. These partnerships enhance the research efforts and foster a collaborative environment aimed at tackling complex medical challenges.
Conclusion
Joseph Lustgarten's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. His patents and ongoing contributions are paving the way for more effective cancer therapies, ultimately benefiting patients worldwide.